Chris Sturhahn joined Enfusion as Chief Product Officer in 2024 and leads all product development efforts.
“At Enfusion I see the opportunity to do something truly unique and meaningful for the asset management industry. Managing portfolios and the trade lifecycle are at the very heart of the investment process, and Enfusion’s systems allow our clients to react quickly and efficiently to the latest trends in the market. The technology platform we have is an ideal vehicle to be able to deliver the insights and information needed in real-time so that everyone, from portfolio managers to operations teams, is always up-to-date.”
Prior to Enfusion, Chris served as Chief Product Officer of Analytics at SimCorp, where he led the product and research teams for the Axioma business. Earlier in his career Chris led teams in Analytics and Quantitative solutions at Blackrock, as well as held senior roles at Bloomberg and Barclays, where he worked on the well-known system POINT, part of their Fixed Income Analytics and Indices business.
Chris is a CFA charterholder and holds a bachelor's degree in Computer Science from the University of Illinois at Urbana-Champaign and a Masters of Business Administration from NYU Stern.